martes, 30 de enero de 2024

Individualised, short-course antibiotic treatment versus usual long-course treatment for ventilator-associated pneumonia (REGARD-VAP): a multicentre, individually randomised, open-label, non-inferiority trial

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00418-6/fulltext?dgcid=hubspot_email_conferencealerts_sccm24&utm_campaign=conferencealerts&utm_medium=email&_hsmi=290937100&_hsenc=p2ANqtz-_YnTzTqm-FVixMcR6Ahiq7lWJzRWhc_kdxbG8BHC2qEbRwMokE3HVvK4sP-OSiVvc7bQSlIfU1nfBJP7maeImwq0H_Yw&utm_content=290937100&utm_source=hs_email

No hay comentarios:

Publicar un comentario